Storys zum Thema Enterprises

Folgen
Keine Story zum Thema Enterprises mehr verpassen.
Filtern
  • 06.07.2010 – 18:33

    BioHub, Inc.

    Ground-Breaking Web Platform Revolutionizes Biomedical Research

    Toronto, July 6, 2010 (ots/PRNewswire) - BioHub Inc., announced today the launch of BioHub-Online.org, a first-of- its-kind online platform to facilitate global networking and collaboration among research scientists. Antibodies are biomedical research reagents used for hundreds of thousands of experiments globally. The global market for research antibodies exceeds $2 billion, yet independent studies show that ...

  • 06.07.2010 – 09:06

    Pfizer AG

    Pfizer Announces European Union Approval of a New Form of Lipitor (atorvastatin) for Use in Children

    New York, July 6, 2010 (ots/PRNewswire) - Pfizer Inc. announced it has received European Commission approval of a new chewable form of Lipitor (atorvastatin calcium) suitable for use in children aged 10 or older with high levels of LDL ("bad") cholesterol and high triglycerides due to the inherited disorder familial hypercholesterolemia and other primary causes, ...

  • 02.07.2010 – 14:49

    Biosign Technologies Inc.

    Biosign Signs European Distribution Agreement

    Toronto, July 2, 2010 (ots/PRNewswire) - Biosign Technologies Inc. (CNSX: BIO) today announced the signing of an exclusive Master Distribution Agreement with Swiss-based DynamiCARE AG to distribute the Biosign products in Switzerland, Germany, France, and Austria, with an option to expand distribution throughout Europe. Under the terms of the agreement, DynamiCARE will pay an initial fee of CDN $2.5 million, with a ...

  • 02.07.2010 – 11:07

    Groupe Pierre Fabre

    Olivier Bohuon Joins Pierre Fabre

    Castres, France, July 2, 2010 (ots/PRNewswire) - Olivier Bohuon will be replacing Jean-Pierre Garnier as Chief Executive Officer at Pierre Fabre Group starting September 1, 2010. Until now, Olivier Bohuon, 51, was Executive Vice-President of the Abbott Corporation and President of its pharmaceutical division. As such, he ran the group's entire pharmaceutical activities from Chicago ($22 billion in sales). In 2003, he was named the group's President for European ...

  • 24.06.2010 – 14:00

    MDS Inc and MDS Nordion

    MDS Nordion, Guerbet, and Cyceron Announce Partnership to Develop New Diagnostic Agents

    Ottawa, June 24, 2010 (ots/PRNewswire) - MDS Nordion, a leading provider of products and services to the global health science market, Guerbet, a pharmaceutical group specialized in medical imaging, and Cyceron, a biomedical imaging centre in France, announced today they have entered into an agreement to develop new Positron Emission Tomography (PET) radiotracers ...

  • 23.06.2010 – 10:04

    TechTeam Global, Inc.

    TechTeam Global to Help Europcar Improve and Expand IT Service Desk Support

    Brussels, June 23, 2010 (ots/PRNewswire) - TechTeam Global, Inc. , a worldwide provider of information technology outsourcing and business process outsourcing services, announced today that it has won a three-year contract to provide service desk support to Europcar, the European leader in passenger car and light utility vehicle rentals. Under the agreement, ...

  • 22.06.2010 – 17:30

    Resverlogix Corp.

    Resverlogix Scientific Data Presented at EAS Congress

    Hamburg and Calgary, Canada, June 22, 2010 (ots/PRNewswire) - Resverlogix Corp. ("Resverlogix" or the "Company") announced today that key scientific data was communicated in an oral presentation highlighting the novel features of the Company's lead drug RVX-208 at the European Atherosclerosis Society Congress (EAS) conference being held in Hamburg, Germany. The presentation titled "RVX-208 given orally raises ...

  • 21.06.2010 – 15:31

    Daiichi Sankyo

    Patients with Hypertension at Risk Due to Physician Inertia

    Oslo, June 21, 2010 (ots/PRNewswire) - Data announced for the first time at ESH suggest that patients with hypertension are at increased cardiovascular risk due to clinician inertia, because physicians are failing to treat targets set by accepted ESH-ESC (European Society of Hypertension and European Society of Cardiology) guidelines for the management of arterial hypertension and do not act soon enough to reduce blood ...